277 related articles for article (PubMed ID: 31877502)
1. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
[TBL] [Abstract][Full Text] [Related]
2. Understanding financial toxicity in head and neck cancer survivors.
Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
[TBL] [Abstract][Full Text] [Related]
3. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
Diao K; Lei X; Smith GL; Jagsi R; Peterson SE; Sumer BD; Smith BD; Sher DJ
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):142-153. PubMed ID: 36812043
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors.
Ver Hoeve ES; Ali-Akbarian L; Price SN; Lothfi NM; Hamann HA
Support Care Cancer; 2021 Jan; 29(1):349-358. PubMed ID: 32361832
[TBL] [Abstract][Full Text] [Related]
5. Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer.
Honda K; Gyawali B; Ando M; Kumanishi R; Kato K; Sugiyama K; Mitani S; Masuishi T; Narita Y; Bando H; Taniguchi H; Kadowaki S; Ura T; Muro K
J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31070981
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.
Yap SL; Wong SS; Chew KS; Kueh JS; Siew KL
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3077-3083. PubMed ID: 33112570
[TBL] [Abstract][Full Text] [Related]
7. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
[TBL] [Abstract][Full Text] [Related]
8. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
Jing J; Feng R; Zhang X; Li M; Gao J
Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
[TBL] [Abstract][Full Text] [Related]
9. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Patient-Centered Financial Stress in Patients With Locally Advanced Head and Neck Cancer.
de Souza JA; Kung S; O'Connor J; Yap BJ
J Oncol Pract; 2017 Apr; 13(4):e310-e318. PubMed ID: 28195811
[TBL] [Abstract][Full Text] [Related]
11. Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country.
Ting CY; Teh GC; Yu KL; Alias H; Tan HM; Wong LP
Support Care Cancer; 2020 Apr; 28(4):1703-1715. PubMed ID: 31292755
[TBL] [Abstract][Full Text] [Related]
12. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
[TBL] [Abstract][Full Text] [Related]
13. Financial toxicity of patients with lung cancer in China: Results from a National Survey Study.
Liu M; Huang D; Liu Y
Cancer Med; 2023 Feb; 12(4):4751-4760. PubMed ID: 36128854
[TBL] [Abstract][Full Text] [Related]
14. The financial impact of cancer care on renal cancer patients.
Ezeife DA; Morganstein BJ; Yip S; Ryan M; Law JH; Guan AY; Le LW; Hansen AR; Sacher A; Bjarnason GA; Doherty MK; Leighl NB
Can J Urol; 2021 Aug; 28(4):10762-10767. PubMed ID: 34378512
[TBL] [Abstract][Full Text] [Related]
15. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
[TBL] [Abstract][Full Text] [Related]
16. Financial toxicity assessment and associated factors analysis of patients with cancer in China.
Qiu Z; Yao L; Jiang J
Support Care Cancer; 2023 Apr; 31(5):264. PubMed ID: 37058171
[TBL] [Abstract][Full Text] [Related]
17. Incremental and comparative health care expenditures for head and neck cancer in the United States.
Dwojak SM; Bhattacharyya N
Laryngoscope; 2014 Oct; 124(10):2305-8. PubMed ID: 24939610
[TBL] [Abstract][Full Text] [Related]
18. Financial burden among older, long-term cancer survivors: Results from the LILAC study.
Hastert TA; Young GS; Pennell ML; Padamsee T; Zafar SY; DeGraffinreid C; Naughton M; Simon M; Paskett ED
Cancer Med; 2018 Sep; 7(9):4261-4272. PubMed ID: 30019387
[TBL] [Abstract][Full Text] [Related]
19. A national cross-sectional survey of financial toxicity among bladder cancer patients.
Ehlers M; Bjurlin M; Gore J; Pruthi R; Narang G; Tan R; Nielsen M; Zhu A; Deal A; Smith A
Urol Oncol; 2021 Jan; 39(1):76.e1-76.e7. PubMed ID: 33268274
[TBL] [Abstract][Full Text] [Related]
20. Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
Lenze NR; Bensen JT; Farnan L; Sheth S; Zevallos JP; Yarbrough WG; Zanation AM
Head Neck; 2022 Feb; 44(2):412-419. PubMed ID: 34793605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
